Richard S. Kolomejec
Defective Drug Recalls Lawyer
As the son of immigrants himself, along with being married to a first generation Croatian-American, Richard brings a level of understanding to his clients that is difficult to duplicate. He believes in the strength of the immigrant heritage of the United States and is passionate about guiding his clients through the complex and sometimes confusing immigration process personal injury law.
His practice is 100% devoted to immigration law and specializes in marriage to US citizen cases. He believes in providing the best representation possible through his experience, dedication and extensive legal knowledge of immigration law. You can count on him to address all of your concerns in a professional, straight forward, easy to understand and courteous manner. Richard prides himself on being a fearless advocate who goes above and beyond expectations when it comes to helping clients get the outcome they deserve. He is dedicated to providing you with compassion, understanding, and fast-paced immigration services, all at fair and reasonable prices, with easy payment plans and credit card processing. When your future and immigration status is on the line, you want to be confident that you are working with a reliable attorney who focuses exclusively on immigration law and takes a personal interest in your case and its outcome.
Christopher B. Dolan
Defective Drug Recalls Lawyer
Possessing a “history of winning multi-million judgments for his clients,” as noted by the San Francisco Business Times, Chris has successfully tried over 46 cases and settled hundreds of lawsuits on favorable terms for his clients.
Chris supervises all cases litigated by the Dolan Law Firm. He has obtained jury verdicts or settlements of more than $1 million in over 26 cases. Some of the settlements in these cases were for amounts exceeding $10 million but were confidential and cannot be listed.
Chris’ unparalleled success in civil litigation includes the largest verdict – $61 million – ever in U.S. history for individuals subjected to racial and ethnic discrimination and harassment in violation of their civil rights. The case involved two Lebanese-Americans who after 9/11 were repeatedly taunted by their manager and coworkers as “terrorists,” “sand niggers,” and other slurs.
Demonstrating Chris’ passion for justice and commitment to his clients no matter the prejudice in society, Chris took the case after 10 other law firms, the NAACP, and ACLU all had rejected it. For his outstanding success in the case, California Lawyer magazine awarded Chris its prestigious California Lawyer of the Year Award.
Lucy S. McAllister J.D.
Defective Drug Recalls Lawyer
Lucy S. McAllister J.D. is an experienced, proactive and diligent license defense lawyer, representing professionals across multiple industry sectors throughout the State of California. She has over 30 years of administrative legal experience with a track record of proven success and will work vigorously to determine the best solution for your professional licensing issue.
Since 1988, she has represented hundreds of individuals either trying to obtain their professional license for the first time looking to avoid discipline, such as the suspension or revocation, of their license. She has represented teachers, nurses (both registered nurses and licensed vocational nurses), psychotherapists, contractors, real estate agents and brokers, insurance salespersons and agents, medical doctors, psychologists, and many other types of professionals in California.
As your attorney, Lucy McAllister will also help you resolve your legal issues in as timely and discreet a manner possible to help preserve your livelihood and have you back in practice as soon as possible.
ARIA MIRAN, ESQ.
Defective Drug Recalls Lawyer
Since being admitted to the California Bar in 2012, Aria Miran has successfully and aggressively settled thousands of personal injury claims. Aria is an expert in car accidents, motorcycle accidents, truck accidents, dog bites, and slip & falls. He also operates at the cutting edge of the law by holding insurance companies responsible for their bad faith handling of insurance claims.
Aria grew up knowing he was meant to be a lawyer, but he did not know what type of attorney he would be until he was 18 years old. When he was in high school, Aria was stopped at a red light when a drunk driver rear-ended his car.
His injuries from the accident initially seemed minor, but they grew progressively worse and ultimately led to major spinal surgery while he was in college. Having experienced the pain and inconvenience that comes with a spinal injury, Aria takes all of his cases very personally and has dedicated his practice to helping plaintiffs who are in a terrible position aggressively pursue their claims against the insurance companies responsible.
Aria began practicing personal injury law after graduating with a Juris Doctor from Loyola Law School Los Angeles. In law school, Aria was a member of the Scott Moot Court honor board, where he honed his skills in written and oral advocacy. He was also selected to judge Appellate Advocacy competitions.
Philip Alexander
Defective Drug Recalls Lawyer
Education
Law School
Georgetown University
Washington, D.C.
Penn State
State College, Pennsylvania
Philip Alexander decided early in high school that he wanted to become a lawyer because he enjoyed helping people and saw the wide range of fields available to assist clients in navigating complex legal situations.
Since becoming a lawyer, Philip has assisted his clients in a variety of injury cases, and some of his recent litigation accomplishments include settlements in the cases of D.L.v. HMS Construction, Inc. et al. for $21.5 million, Thrasher v. Luna et. al. for $2,450,000, Lashlee v Huerta-Chicas for $2,000,000, and McClaughry v. TVUSD for $1,000,000. When he is not working, Philip enjoys spending time with his wife and children, traveling, golfing, and watching the Los Angeles Chargers.
William Green
Defective Drug Recalls Lawyer
Mr. Green has dedicated his legal career to helping people who are injured or disabled. Mr. Green grew up in southern California, where he started from very modest beginnings. Through hard work and by earning scholarships, he was able to graduate with honors from College and Law School.
In College, Mr. Green earned a double major in Legal Studies and Philosophy. In Law School at the prestigious University of California, Hastings College of the Law, Mr. Green, earned writing awards such as “Best Brief” in a class of over 500 law students, and was selected to represent the entire Law School in the “National Moot Court Competition.”
Since beginning his practice many years ago, Mr. Green has made a career of championing the rights of the most vulnerable members of society – injury victims and disabled people – against the most powerful corporations, government entities, and insurance companies. Where most attorneys take on “a case,” Mr. Green frequently comments that he takes on clients and their cause.
JAMES REILLY
Defective Drug Recalls Lawyer
In one case result that Jim is particularly proud of, our client was accused of molesting two children and was facing life in prison. Following a three week trial, Jim hung the jury, persuaded the DA not to refile and ultimately secured a dismissal in the case. Our client is now home with his family. At the conclusion of the trial, the judge made the following remarks on the record about Jim’s defense:
Who Is Responsible for the Drug Recall Process?
Drug recalls are essential mechanisms in the pharmaceutical industry, designed to protect public health by removing potentially harmful, defective, or substandard medications from the market. The process of recalling a drug is complex, involving multiple stakeholders, each with distinct responsibilities. Understanding who is responsible for the drug recall process is crucial for ensuring transparency, accountability, and the safety of patients and consumers.
The Primary Responsibility: Drug Manufacturers and License Holders
The foremost responsibility for initiating and managing a drug recall lies with the drug manufacturer or the license holder. These are the entities that produce, market, and distribute pharmaceutical products. Manufacturers are legally and ethically obliged to ensure the safety, efficacy, and quality of their products at all stages—from production to delivery.
If a manufacturer discovers a defect—such as contamination, incorrect labeling, or a batch that fails quality standards—they are responsible for immediately notifying the relevant regulatory authorities and initiating a recall. The recall may be voluntary, where the company acts on its own findings, or it may be mandated by a regulatory body following an inspection, adverse event report, or consumer complaint.
Manufacturers must have robust recall procedures in place, including systems for tracking product distribution, notifying stakeholders, and retrieving affected products from the market. They are also responsible for investigating the root cause of the issue, implementing corrective actions, and reporting the outcomes of the recall to regulatory authorities.
The Oversight Role: Regulatory Authorities
National and regional regulatory authorities play a supervisory and enforcement role in the drug recall process. In India, the Central Drugs Standard Control Organization (CDSCO) and State Licensing Authorities (SLAs) oversee drug recalls. In the United States, this responsibility falls to the Food and Drug Administration (FDA), while the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) perform similar functions in Europe and the UK, respectively.
Regulatory authorities are responsible for:
Monitoring Drug Safety: They continuously monitor the safety, efficacy, and quality of drugs through post-marketing surveillance, adverse event reporting systems, and routine inspections.
Mandating Recalls: If a regulatory agency identifies a significant risk to public health, it can mandate a recall, even if the manufacturer has not initiated one.
Classifying Recalls: Agencies classify recalls based on the severity of the risk (e.g., Class I for life-threatening risks, Class II for temporary health problems, and Class III for minor defects).
Communicating with the Public: Regulatory bodies issue public notifications, press releases, and updates to inform healthcare professionals and consumers about recalls.
Auditing and Follow-up: They ensure that the recall process is executed effectively, monitor compliance, and may conduct audits or inspections to verify that recalled products are removed from the market.
State Licensing Authorities and Coordination
In India, State Licensing Authorities (SLAs) or the Central Licensing Approving Authority (CLAA) have a crucial role in the recall process. They are responsible for issuing formal recall orders, especially when the issue pertains to products distributed across multiple states. SLAs coordinate with zonal offices and other state authorities to ensure that the recall is effectively implemented at all levels.
The Distribution Chain: Distributors, Stockists, and Retailers
Once a recall is initiated, the responsibility extends to all entities in the distribution chain, including distributors, stockists, and retailers. These stakeholders must:
Identify and Isolate Recalled Products: They are responsible for identifying the affected batches in their inventory and preventing further distribution or sale.
Notify Upstream and Downstream Partners: Distributors and retailers must inform their suppliers and customers about the recall, ensuring that the information reaches every level of the supply chain.
Return or Dispose of Products: Recalled products must be returned to the manufacturer or destroyed in accordance with regulatory guidelines.
Pharmacists and Healthcare Providers
Pharmacists and healthcare professionals are on the front lines of patient care and play a vital role in the recall process. Their responsibilities include:
Identifying Recalled Medications: Pharmacists must regularly check recall notices and remove affected products from their shelves.
Informing Patients: When patients have already received the recalled medication, pharmacists and healthcare providers must inform them about the recall, advise on next steps, and, if necessary, provide alternative treatments.
Reporting Adverse Events: Healthcare professionals are often the first to observe adverse reactions or therapeutic failures, and they must report these incidents to regulatory authorities, which can trigger investigations and recalls.
The Drug Recall Process: Step-by-Step
The drug recall process typically follows these steps:
Detection of a Problem: A defect or safety issue is identified through quality control, adverse event reports, inspections, or consumer complaints.
Risk Assessment: The manufacturer and regulatory authorities assess the risk to public health and determine the recall’s classification.
Notification and Communication: All stakeholders, including distributors, healthcare providers, and the public, are notified about the recall.
Product Removal: The affected product is removed from the market, and corrective actions are implemented.
Follow-up and Reporting: The effectiveness of the recall is monitored, and a final report is submitted to regulatory authorities.
Conclusion
The responsibility for the drug recall process is a collaborative effort involving manufacturers, regulatory authorities, state agencies, distributors, retailers, pharmacists, and healthcare professionals. Each stakeholder has a vital role in ensuring that defective or dangerous drugs are swiftly and efficiently removed from the market. This collective vigilance and coordinated action protect public health and maintain trust in the pharmaceutical system.